首页> 美国卫生研究院文献>Molecular Cellular Proteomics : MCP >Quantitative Proteomics of Strong and Weak Biofilm Formers of Enterococcus faecalis Reveals Novel Regulators of Biofilm Formation
【2h】

Quantitative Proteomics of Strong and Weak Biofilm Formers of Enterococcus faecalis Reveals Novel Regulators of Biofilm Formation

机译:粪肠球菌强而弱的生物膜形成者的定量蛋白质组学揭示了生物膜形成的新型调节剂。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Enterococcus faecalis is a bacterial pathogen associated with both endodontic and systemic infections. The biofilm formation ability of E. faecalis plays a key role in its virulence and drug resistance attributes. The formation of E. faecalis biofilms on implanted medical devices often results in treatment failure. In the present study, we report protein markers associated with the biofilm formation ability of E. faecalis using iTRAQ-based quantitative proteomics approach. In order to elucidate the biofilm-associated protein markers, we investigated the proteome of strong and weak biofilm-forming E. faecalis clinical isolates in comparison with standard American Type Culture Collection (ATCC) control strains. Comparison of E. faecalis strong and weak biofilm-forming clinical isolates with ATCC control strains showed that proteins associated with shikimate kinase pathway and sulfate transport were up-regulated in the strong biofilm former, while proteins associated with secondary metabolites, cofactor biosynthesis, and tetrahydrofolate biosynthesis were down-regulated. In the weak biofilm former, proteins associated with nucleoside and nucleotide biosynthesis were up-regulated, whereas proteins associated with sulfate and sugar transport were down-regulated. Further pathway and gene ontology analyses revealed that the major differences in biofilm formation arise from differences in metabolic activity levels of the strong and weak biofilm formers, with higher levels of metabolic activity observed in the weak biofilm former. The differences in metabolic activity could therefore be a major determinant of the biofilm ability of E. faecalis. The new markers identified from this study can be further characterized in order to understand their exact role in E. faecalis biofilm formation ability. This, in turn, can lead to numerous therapeutic benefits in the treatment of this oral and systemic pathogen. The data has been deposited to the ProteomeXchange with identifier PXD006542.
机译:粪肠球菌是与牙髓和全身感染相关的细菌病原体。粪肠球菌的生物膜形成能力在其毒力和耐药性属性中起关键作用。在植入的医疗设备上粪肠球菌生物膜的形成通常会导致治疗失败。在本研究中,我们报告了使用基于iTRAQ的定量蛋白质组学方法与粪肠球菌生物膜形成能力相关的蛋白质标记。为了阐明与生物膜相关的蛋白质标记,我们与标准美国典型培养物保藏中心(ATCC)对照菌株进行了比较,研究了形成强生物膜和弱生物膜的粪肠球菌临床分离株的蛋白质组。粪肠球菌形成强和弱生物膜的临床分离株与ATCC对照菌株的比较显示,在强生物膜形成剂中与sh草酸激酶途径和硫酸盐转运相关的蛋白被上调,而与次生代谢产物,辅因子生物合成和四氢叶酸相关的蛋白生物合成被下调。在薄弱的生物膜形成剂中,与核苷和核苷酸生物合成相关的蛋白被上调,而与硫酸盐和糖转运相关的蛋白被下调。进一步的途径和基因本体分析表明,生物膜形成的主要差异来自强生物膜形成者和弱生物膜形成者的代谢活性水平的差异,而在弱生物膜形成者中观察到更高水平的代谢活性。因此,代谢活性的差异可能是粪肠球菌生物膜能力的主要决定因素。从这项研究中鉴定出的新标记可以进一步表征,以了解它们在粪肠球菌生物膜形成能力中的确切作用。反过来,这可以在治疗这种口腔和全身性病原体方面带来许多治疗益处。数据已存储到ProteomeXchange,标识符为PXD006542。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号